---
import Layout from '../../layouts/Layout.astro';
---

<Layout title="Recurrent Pregnancy Loss" description="Understanding recurrent pregnancy loss including miscarriage statistics, causes, diagnostic testing, and treatment options after multiple miscarriages.">
	<section class="hero-mini">
		<div class="container">
			<nav class="breadcrumb">
				<a href="/">Home</a>
				<span>‚Üí</span>
				<a href="/treatments/">Treatments</a>
				<span>‚Üí</span>
				<span>Recurrent Loss</span>
			</nav>
			<h1>Recurrent Pregnancy Loss</h1>
			<p>Understanding, testing, and treatment options after multiple miscarriages.</p>
		</div>
	</section>

	<section class="content-section">
		<div class="container">
			<div class="intro-box">
				<p>Miscarriage is far more common than many people realize, affecting up to 26% of all pregnancies. Understanding these statistics and the causes of recurrent loss can help reduce isolation, guide treatment decisions, and provide hope for future pregnancies.</p>
			</div>

			<h2>Miscarriage Statistics</h2>

			<div class="stats-grid">
				<div class="stat-card">
					<div class="stat-icon">üìä</div>
					<div class="stat-number">10-15%</div>
					<div class="stat-label">Clinically recognized pregnancies</div>
					<div class="stat-detail">End in miscarriage</div>
				</div>
				<div class="stat-card">
					<div class="stat-icon">üìà</div>
					<div class="stat-number">~26%</div>
					<div class="stat-label">All pregnancies</div>
					<div class="stat-detail">Including very early losses</div>
				</div>
				<div class="stat-card">
					<div class="stat-icon">‚è∞</div>
					<div class="stat-number">80%</div>
					<div class="stat-label">First trimester</div>
					<div class="stat-detail">When most miscarriages occur</div>
				</div>
				<div class="stat-card">
					<div class="stat-icon">üß¨</div>
					<div class="stat-number">50-60%</div>
					<div class="stat-label">Chromosomal cause</div>
					<div class="stat-detail">Primary cause of loss</div>
				</div>
			</div>

			<div class="callout callout-info">
				<span class="callout-icon">üåç</span>
				<div class="callout-content">
					<strong>Global Impact:</strong> An estimated 23 million miscarriages occur worldwide each year‚Äîthat's 44 per minute. You are not alone.
				</div>
			</div>

			<p class="citation">Sources: <a href="https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2018/11/early-pregnancy-loss" target="_blank" rel="noopener">ACOG Practice Bulletin</a>, <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00682-6/abstract" target="_blank" rel="noopener">The Lancet 2021</a></p>

			<h2>Miscarriage Risk by Age</h2>

			<div class="table-container">
				<table class="styled-table">
					<thead>
						<tr>
							<th>Age</th>
							<th>Miscarriage Risk</th>
							<th>Notes</th>
						</tr>
					</thead>
					<tbody>
						<tr>
							<td><strong>Under 30</strong></td>
							<td>~10%</td>
							<td>Lowest risk period</td>
						</tr>
						<tr>
							<td><strong>30-34</strong></td>
							<td>~12%</td>
							<td>Slight increase</td>
						</tr>
						<tr>
							<td><strong>35-39</strong></td>
							<td>~18%</td>
							<td>Moderate increase</td>
						</tr>
						<tr>
							<td><strong>40-44</strong></td>
							<td>~34%</td>
							<td>Significant increase</td>
						</tr>
						<tr>
							<td><strong>Over 45</strong></td>
							<td>~53%</td>
							<td>Highest risk</td>
						</tr>
					</tbody>
				</table>
			</div>

			<p class="citation">Source: <a href="https://www.ncbi.nlm.nih.gov/books/NBK532992/" target="_blank" rel="noopener">NCBI StatPearls - Miscarriage</a></p>

			<h3>Risk Decreases as Pregnancy Progresses</h3>

			<div class="progress-timeline">
				<div class="progress-item">
					<div class="progress-dot high-risk"></div>
					<div class="progress-content">
						<span class="progress-stage">Before heartbeat</span>
						<span class="progress-risk">10-20% risk</span>
					</div>
				</div>
				<div class="progress-item">
					<div class="progress-dot medium-risk"></div>
					<div class="progress-content">
						<span class="progress-stage">After heartbeat (6-7 weeks)</span>
						<span class="progress-risk">&lt;5% risk</span>
					</div>
				</div>
				<div class="progress-item">
					<div class="progress-dot low-risk"></div>
					<div class="progress-content">
						<span class="progress-stage">After 12 weeks</span>
						<span class="progress-risk">1-2% risk</span>
					</div>
				</div>
				<div class="progress-item">
					<div class="progress-dot very-low-risk"></div>
					<div class="progress-content">
						<span class="progress-stage">After 20 weeks</span>
						<span class="progress-risk">&lt;1% risk</span>
					</div>
				</div>
			</div>

			<h2>What is Recurrent Pregnancy Loss?</h2>

			<div class="definition-box">
				<h3>ASRM Definition</h3>
				<p>Recurrent pregnancy loss (RPL) is defined as <strong>two or more</strong> pregnancy losses before 20 weeks gestation. It affects <strong>2-4% of couples</strong> trying to conceive.</p>
			</div>

			<div class="stats-grid stats-grid-3">
				<div class="stat-card">
					<div class="stat-number">2-4%</div>
					<div class="stat-label">Experience 2+ losses</div>
				</div>
				<div class="stat-card">
					<div class="stat-number">0.5-1%</div>
					<div class="stat-label">Experience 3+ losses</div>
				</div>
				<div class="stat-card highlight">
					<div class="stat-number">60-75%</div>
					<div class="stat-label">Success in next pregnancy</div>
					<div class="stat-detail">(with unexplained RPL)</div>
				</div>
			</div>

			<div class="callout callout-warning">
				<span class="callout-icon">‚è±Ô∏è</span>
				<div class="callout-content">
					<strong>When to seek evaluation:</strong> ASRM recommends a full RPL workup after 2 consecutive losses, especially if you're over 35. Don't wait for a third loss to get answers.
				</div>
			</div>

			<p class="citation">Sources: <a href="https://www.asrm.org/practice-guidance/practice-committee-documents/evaluation-and-treatment-of-recurrent-pregnancy-loss-a-committee-opinion-2012/" target="_blank" rel="noopener">ASRM Committee Opinion</a>, <a href="https://www.ncbi.nlm.nih.gov/books/NBK554460/" target="_blank" rel="noopener">NCBI StatPearls - RPL</a></p>

			<h2>Causes of Recurrent Loss</h2>

			<p>When miscarriage tissue is tested along with standard RPL workup, a cause can be identified in <strong>over 90%</strong> of cases. The most common cause is chromosomal abnormality in the embryo.</p>

			<div class="table-container">
				<table class="styled-table causes-table">
					<thead>
						<tr>
							<th>Category</th>
							<th>Cause</th>
							<th>Frequency</th>
						</tr>
					</thead>
					<tbody>
						<tr class="category-genetic">
							<td><span class="category-badge genetic">Genetic</span></td>
							<td>Embryo aneuploidy (random chromosomal errors)</td>
							<td><strong>50-60%</strong> of losses</td>
						</tr>
						<tr class="category-genetic">
							<td><span class="category-badge genetic">Genetic</span></td>
							<td>Parental balanced translocation</td>
							<td>2-5% of couples</td>
						</tr>
						<tr class="category-uterine">
							<td><span class="category-badge uterine">Uterine</span></td>
							<td>Uterine septum</td>
							<td>3-5%</td>
						</tr>
						<tr class="category-uterine">
							<td><span class="category-badge uterine">Uterine</span></td>
							<td>Fibroids (submucosal)</td>
							<td>5-10%</td>
						</tr>
						<tr class="category-uterine">
							<td><span class="category-badge uterine">Uterine</span></td>
							<td>Asherman's syndrome (scarring)</td>
							<td>5%</td>
						</tr>
						<tr class="category-blood">
							<td><span class="category-badge blood">Thrombophilia</span></td>
							<td>Antiphospholipid syndrome (APS)</td>
							<td>5-15%</td>
						</tr>
						<tr class="category-blood">
							<td><span class="category-badge blood">Thrombophilia</span></td>
							<td>Inherited clotting disorders</td>
							<td>5-10%</td>
						</tr>
						<tr class="category-endocrine">
							<td><span class="category-badge endocrine">Endocrine</span></td>
							<td>Thyroid dysfunction</td>
							<td>5-10%</td>
						</tr>
						<tr class="category-endocrine">
							<td><span class="category-badge endocrine">Endocrine</span></td>
							<td>Uncontrolled diabetes</td>
							<td>Variable</td>
						</tr>
						<tr class="category-endocrine">
							<td><span class="category-badge endocrine">Endocrine</span></td>
							<td>Low progesterone / luteal phase defect</td>
							<td>Debated</td>
						</tr>
						<tr class="category-immune">
							<td><span class="category-badge immune">Immune</span></td>
							<td>Natural killer cell abnormalities</td>
							<td>Controversial</td>
						</tr>
						<tr class="category-unknown">
							<td><span class="category-badge unknown">Unknown</span></td>
							<td>No identifiable cause</td>
							<td>40-50%</td>
						</tr>
					</tbody>
				</table>
			</div>

			<p class="citation">Sources: <a href="https://www.asrm.org/practice-guidance/practice-committee-documents/evaluation-and-treatment-of-recurrent-pregnancy-loss-a-committee-opinion-2012/" target="_blank" rel="noopener">ASRM Committee Opinion on RPL</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/29538673/" target="_blank" rel="noopener">Human Reproduction 2018</a>, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3824507/" target="_blank" rel="noopener">PMC - Chromosomal Abnormalities in RPL</a></p>

			<div class="callout callout-info">
				<span class="callout-icon">üî¨</span>
				<div class="callout-content">
					<strong>POC Testing:</strong> When products of conception (miscarriage tissue) are tested with chromosomal microarray, <strong>67%</strong> show a genetic abnormality‚Äîmost commonly trisomy (79% of abnormalities). This testing can provide answers and guide treatment.
				</div>
			</div>

			<h2>RPL Testing Workup</h2>

			<h3>Standard Testing (Recommended)</h3>

			<div class="testing-grid">
				<div class="testing-card">
					<div class="testing-header">
						<span class="testing-icon">üß¨</span>
						<h4>Genetic Testing</h4>
					</div>
					<ul>
						<li><strong>Karyotype (both partners):</strong> Blood test for balanced translocations or chromosomal rearrangements</li>
						<li><strong>POC testing:</strong> Genetic analysis of miscarriage tissue</li>
					</ul>
					<div class="testing-cost">
						<span class="cost-label">Typical Cost:</span>
						<span class="cost-amount">$200-$500 per karyotype; $500-$1,500 for POC</span>
					</div>
				</div>

				<div class="testing-card">
					<div class="testing-header">
						<span class="testing-icon">üîç</span>
						<h4>Uterine Evaluation</h4>
					</div>
					<ul>
						<li><strong>Transvaginal ultrasound:</strong> Basic uterine assessment</li>
						<li><strong>Saline sonogram (SIS):</strong> Enhanced cavity visualization</li>
						<li><strong>Hysteroscopy:</strong> Direct visualization and treatment</li>
						<li><strong>MRI:</strong> If anomaly suspected</li>
					</ul>
					<div class="testing-cost">
						<span class="cost-label">Typical Cost:</span>
						<span class="cost-amount">$300-$1,000 imaging; $2,000-$10,000 hysteroscopy</span>
					</div>
				</div>

				<div class="testing-card">
					<div class="testing-header">
						<span class="testing-icon">ü©∏</span>
						<h4>Blood Clotting Panel</h4>
					</div>
					<ul>
						<li><strong>Antiphospholipid antibodies:</strong> Lupus anticoagulant, anticardiolipin, beta-2 glycoprotein</li>
						<li><strong>Factor V Leiden</strong></li>
						<li><strong>Prothrombin gene mutation</strong></li>
						<li><strong>Protein C, S, Antithrombin III</strong></li>
					</ul>
					<div class="testing-cost">
						<span class="cost-label">Typical Cost:</span>
						<span class="cost-amount">$500-$2,000</span>
					</div>
				</div>

				<div class="testing-card">
					<div class="testing-header">
						<span class="testing-icon">‚öóÔ∏è</span>
						<h4>Hormonal Testing</h4>
					</div>
					<ul>
						<li><strong>TSH and thyroid antibodies</strong></li>
						<li><strong>Prolactin</strong></li>
						<li><strong>Hemoglobin A1C</strong> (diabetes screening)</li>
						<li><strong>Day 3 FSH, estradiol, AMH</strong></li>
						<li><strong>Progesterone</strong> (mid-luteal phase)</li>
					</ul>
					<div class="testing-cost">
						<span class="cost-label">Typical Cost:</span>
						<span class="cost-amount">$200-$800</span>
					</div>
				</div>
			</div>

			<h3>Additional Testing (Case-by-Case)</h3>

			<div class="additional-tests">
				<div class="test-item">
					<strong>Endometrial biopsy</strong>
					<span>Check for chronic endometritis (infection)</span>
				</div>
				<div class="test-item">
					<strong>Sperm DNA fragmentation</strong>
					<span>If male factor suspected</span>
				</div>
				<div class="test-item">
					<strong>ERA (Endometrial Receptivity Analysis)</strong>
					<span>Timing of implantation window</span>
				</div>
				<div class="test-item">
					<strong>Immunological panels</strong>
					<span>NK cells, cytokines (controversial)</span>
				</div>
			</div>

			<div class="callout callout-warning">
				<span class="callout-icon">‚ö†Ô∏è</span>
				<div class="callout-content">
					<strong>Note on immune testing:</strong> Testing for natural killer cells, cytokines, and other immune factors is controversial. Many reproductive immunology treatments lack strong evidence. Discuss thoroughly with your doctor before pursuing expensive immune protocols.
				</div>
			</div>

			<h2>Treatment Options</h2>

			<h3>Treatments for Identified Causes</h3>

			<div class="treatment-cards">
				<div class="treatment-card">
					<div class="treatment-header aps">
						<h4>Antiphospholipid Syndrome (APS)</h4>
						<span class="success-badge">70-80% success</span>
					</div>
					<div class="treatment-body">
						<p><strong>Treatment:</strong> Low-dose aspirin (81mg daily) + heparin or Lovenox injections throughout pregnancy</p>
						<p class="contrast-note">Without treatment: 10-20% live birth rate</p>
						<div class="treatment-cost">$100-$500/month</div>
					</div>
				</div>

				<div class="treatment-card">
					<div class="treatment-header uterine">
						<h4>Uterine Abnormalities</h4>
						<span class="success-badge">Varies by condition</span>
					</div>
					<div class="treatment-body">
						<p><strong>Treatment:</strong> Surgical correction via hysteroscopy</p>
						<ul>
							<li>Septum resection</li>
							<li>Fibroid removal (myomectomy)</li>
							<li>Adhesion removal (for Asherman's)</li>
						</ul>
						<div class="treatment-cost">$5,000-$15,000</div>
					</div>
				</div>

				<div class="treatment-card">
					<div class="treatment-header genetic">
						<h4>Parental Chromosomal Translocation</h4>
						<span class="success-badge">Significantly reduces risk</span>
					</div>
					<div class="treatment-body">
						<p><strong>Treatment:</strong> IVF with PGT-SR (preimplantation genetic testing for structural rearrangements)</p>
						<p>Tests embryos before transfer to select those with normal chromosomes.</p>
						<div class="treatment-cost">$20,000-$35,000/cycle</div>
					</div>
				</div>

				<div class="treatment-card">
					<div class="treatment-header thyroid">
						<h4>Thyroid Dysfunction</h4>
						<span class="success-badge">Goal: TSH &lt;2.5</span>
					</div>
					<div class="treatment-body">
						<p><strong>Treatment:</strong> Thyroid medication (levothyroxine) to normalize TSH levels during pregnancy</p>
						<div class="treatment-cost">$10-$50/month</div>
					</div>
				</div>
			</div>

			<h3>Empiric Treatments (When Cause Unknown)</h3>

			<div class="empiric-grid">
				<div class="empiric-card">
					<h4>Progesterone Supplementation</h4>
					<p>Vaginal or intramuscular progesterone starting after ovulation or positive test.</p>
					<div class="evidence-note">
						<strong>Evidence:</strong> PRISM trial showed benefit for women with bleeding in early pregnancy and history of loss
					</div>
					<div class="empiric-cost">$50-$300/month</div>
				</div>

				<div class="empiric-card">
					<h4>Baby Aspirin (81mg)</h4>
					<p>Often prescribed empirically even without diagnosed APS.</p>
					<div class="evidence-note">
						<strong>Evidence:</strong> Low risk, may have modest benefit
					</div>
					<div class="empiric-cost">~$10/month</div>
				</div>

				<div class="empiric-card">
					<h4>IVF with PGT-A</h4>
					<p>Testing embryos for chromosomal abnormalities before transfer.</p>
					<div class="evidence-note">
						<strong>Evidence:</strong> Can reduce miscarriage rate per transfer, especially for women over 35
					</div>
					<div class="empiric-cost">$20,000-$30,000</div>
				</div>
			</div>

			<h2>When to Consider Other Options</h2>

			<div class="options-grid">
				<div class="option-card">
					<h3>ü•ö Donor Eggs</h3>
					<p>Consider if:</p>
					<ul>
						<li>Multiple losses with chromosomally abnormal embryos</li>
						<li>Advanced maternal age (40+) with RPL</li>
						<li>PGT-A shows most/all embryos are abnormal</li>
						<li>Diminished ovarian reserve</li>
					</ul>
					<a href="/treatments/third-party/" class="option-link">Learn about donor options ‚Üí</a>
				</div>

				<div class="option-card">
					<h3>ü§∞ Gestational Carrier</h3>
					<p>Consider if:</p>
					<ul>
						<li>Uncorrectable uterine abnormality</li>
						<li>Multiple losses despite normal embryos</li>
						<li>Medical conditions making pregnancy dangerous</li>
					</ul>
					<a href="/treatments/third-party/" class="option-link">Learn about surrogacy ‚Üí</a>
				</div>
			</div>

			<h2>Emotional Support</h2>

			<p>Recurrent loss is emotionally devastating. Taking care of your mental health is just as important as physical treatment.</p>

			<div class="support-options">
				<div class="support-item">
					<span class="support-icon">üí¨</span>
					<div>
						<strong>Counseling</strong>
						<p>Individual or couples therapy with someone experienced in pregnancy loss</p>
					</div>
				</div>
				<div class="support-item">
					<span class="support-icon">üë•</span>
					<div>
						<strong>Support Groups</strong>
						<p>RESOLVE, local pregnancy loss support groups, online communities</p>
					</div>
				</div>
				<div class="support-item">
					<span class="support-icon">‚è∏Ô∏è</span>
					<div>
						<strong>Taking Breaks</strong>
						<p>It's okay to pause between attempts‚Äîhealing takes time</p>
					</div>
				</div>
			</div>

			<div class="callout callout-success">
				<span class="callout-icon">üíö</span>
				<div class="callout-content">
					<strong>There is hope:</strong> Even after 3 unexplained losses, the chance of a successful next pregnancy is 60-75% without any treatment. With appropriate treatment for identified causes, success rates can be even higher.
				</div>
			</div>

			<h2>Questions for Your Doctor</h2>

			<div class="questions-list">
				<div class="question-item">
					<span class="question-number">1</span>
					<span>What testing do you recommend based on my history?</span>
				</div>
				<div class="question-item">
					<span class="question-number">2</span>
					<span>Should we test the pregnancy tissue if another loss occurs?</span>
				</div>
				<div class="question-item">
					<span class="question-number">3</span>
					<span>Do you recommend any empiric treatments?</span>
				</div>
				<div class="question-item">
					<span class="question-number">4</span>
					<span>At what point would you recommend IVF with PGT?</span>
				</div>
				<div class="question-item">
					<span class="question-number">5</span>
					<span>Should I see a reproductive immunologist? (Ask for evidence-based perspective)</span>
				</div>
				<div class="question-item">
					<span class="question-number">6</span>
					<span>What's my prognosis for a successful pregnancy?</span>
				</div>
			</div>

			<nav class="nav-footer">
				<a href="/treatments/surgical/" class="nav-prev">
					<span class="nav-direction">‚Üê Previous</span>
					<span class="nav-title">Surgical Treatments</span>
				</a>
				<a href="/treatments/" class="nav-next">
					<span class="nav-direction">All Treatments</span>
					<span class="nav-title">View All Options ‚Üí</span>
				</a>
			</nav>
		</div>
	</section>
</Layout>

<style>
	.hero-mini {
		background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
		color: white;
		padding: 3rem 0;
	}

	.breadcrumb {
		display: flex;
		align-items: center;
		gap: 0.5rem;
		margin-bottom: 1rem;
		font-size: 0.9rem;
		opacity: 0.9;
	}

	.breadcrumb a {
		color: white;
		text-decoration: none;
	}

	.breadcrumb a:hover {
		text-decoration: underline;
	}

	.hero-mini h1 {
		margin: 0 0 0.5rem;
		font-size: 2.5rem;
	}

	.hero-mini p {
		margin: 0;
		font-size: 1.25rem;
		opacity: 0.9;
	}

	.content-section {
		padding: 3rem 0;
	}

	.intro-box {
		background: linear-gradient(135deg, #f8f9ff 0%, #f0f4ff 100%);
		border-left: 4px solid #667eea;
		padding: 1.5rem;
		margin-bottom: 2.5rem;
		border-radius: 0 8px 8px 0;
		font-size: 1.1rem;
	}

	.intro-box p {
		margin: 0;
	}

	h2 {
		color: #1a202c;
		margin: 2.5rem 0 1.5rem;
		padding-bottom: 0.5rem;
		border-bottom: 2px solid #667eea;
	}

	h3 {
		color: #2d3748;
		margin: 2rem 0 1rem;
	}

	/* Stats Grid */
	.stats-grid {
		display: grid;
		grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
		gap: 1.5rem;
		margin: 1.5rem 0;
	}

	.stats-grid-3 {
		grid-template-columns: repeat(3, 1fr);
	}

	.stat-card {
		background: white;
		border-radius: 12px;
		padding: 1.5rem;
		text-align: center;
		box-shadow: 0 2px 8px rgba(0,0,0,0.08);
		border: 1px solid #e2e8f0;
	}

	.stat-card.highlight {
		background: linear-gradient(135deg, #48bb78 0%, #38a169 100%);
		color: white;
		border: none;
	}

	.stat-icon {
		font-size: 2rem;
		margin-bottom: 0.5rem;
	}

	.stat-number {
		font-size: 2rem;
		font-weight: 700;
		color: #667eea;
	}

	.stat-card.highlight .stat-number {
		color: white;
	}

	.stat-label {
		font-size: 0.95rem;
		color: #4a5568;
		margin-top: 0.25rem;
	}

	.stat-card.highlight .stat-label {
		color: rgba(255,255,255,0.9);
	}

	.stat-detail {
		font-size: 0.85rem;
		color: #718096;
		margin-top: 0.25rem;
	}

	.stat-card.highlight .stat-detail {
		color: rgba(255,255,255,0.8);
	}

	/* Callout Boxes */
	.callout {
		display: flex;
		gap: 1rem;
		padding: 1.25rem;
		border-radius: 8px;
		margin: 1.5rem 0;
	}

	.callout-icon {
		font-size: 1.5rem;
		flex-shrink: 0;
	}

	.callout-content {
		flex: 1;
	}

	.callout-info {
		background: #ebf8ff;
		border: 1px solid #90cdf4;
	}

	.callout-warning {
		background: #fffaf0;
		border: 1px solid #fbd38d;
	}

	.callout-success {
		background: #f0fff4;
		border: 1px solid #9ae6b4;
	}

	.citation {
		font-size: 0.85rem;
		color: #718096;
		margin: 1rem 0;
	}

	.citation a {
		color: #667eea;
	}

	/* Tables */
	.table-container {
		overflow-x: auto;
		margin: 1.5rem 0;
	}

	.styled-table {
		width: 100%;
		border-collapse: collapse;
		font-size: 0.95rem;
	}

	.styled-table thead {
		background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
		color: white;
	}

	.styled-table th {
		padding: 1rem;
		text-align: left;
		font-weight: 600;
	}

	.styled-table td {
		padding: 1rem;
		border-bottom: 1px solid #e2e8f0;
	}

	.styled-table tbody tr:hover {
		background: #f8fafc;
	}

	/* Category Badges */
	.category-badge {
		display: inline-block;
		padding: 0.25rem 0.75rem;
		border-radius: 20px;
		font-size: 0.8rem;
		font-weight: 500;
	}

	.category-badge.genetic {
		background: #e9d8fd;
		color: #553c9a;
	}

	.category-badge.uterine {
		background: #fed7e2;
		color: #97266d;
	}

	.category-badge.blood {
		background: #fed7d7;
		color: #c53030;
	}

	.category-badge.endocrine {
		background: #fefcbf;
		color: #975a16;
	}

	.category-badge.immune {
		background: #c6f6d5;
		color: #276749;
	}

	.category-badge.unknown {
		background: #e2e8f0;
		color: #4a5568;
	}

	/* Progress Timeline */
	.progress-timeline {
		display: flex;
		flex-direction: column;
		gap: 0.5rem;
		margin: 1.5rem 0;
		padding-left: 1rem;
	}

	.progress-item {
		display: flex;
		align-items: center;
		gap: 1rem;
		padding: 0.75rem;
		background: white;
		border-radius: 8px;
		box-shadow: 0 1px 3px rgba(0,0,0,0.1);
	}

	.progress-dot {
		width: 16px;
		height: 16px;
		border-radius: 50%;
		flex-shrink: 0;
	}

	.high-risk { background: #fc8181; }
	.medium-risk { background: #f6ad55; }
	.low-risk { background: #68d391; }
	.very-low-risk { background: #48bb78; }

	.progress-content {
		display: flex;
		justify-content: space-between;
		flex: 1;
	}

	.progress-stage {
		font-weight: 500;
	}

	.progress-risk {
		color: #718096;
	}

	/* Definition Box */
	.definition-box {
		background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
		color: white;
		padding: 1.5rem;
		border-radius: 12px;
		margin: 1.5rem 0;
	}

	.definition-box h3 {
		color: white;
		margin: 0 0 0.75rem;
		font-size: 1rem;
		text-transform: uppercase;
		letter-spacing: 0.05em;
		opacity: 0.9;
	}

	.definition-box p {
		margin: 0;
		font-size: 1.1rem;
	}

	/* Testing Grid */
	.testing-grid {
		display: grid;
		grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
		gap: 1.5rem;
		margin: 1.5rem 0;
	}

	.testing-card {
		background: white;
		border-radius: 12px;
		padding: 1.5rem;
		box-shadow: 0 2px 8px rgba(0,0,0,0.08);
		border: 1px solid #e2e8f0;
	}

	.testing-header {
		display: flex;
		align-items: center;
		gap: 0.75rem;
		margin-bottom: 1rem;
	}

	.testing-icon {
		font-size: 1.5rem;
	}

	.testing-header h4 {
		margin: 0;
		color: #2d3748;
	}

	.testing-card ul {
		margin: 0;
		padding-left: 1.25rem;
	}

	.testing-card li {
		margin-bottom: 0.5rem;
		font-size: 0.95rem;
	}

	.testing-cost {
		margin-top: 1rem;
		padding-top: 1rem;
		border-top: 1px solid #e2e8f0;
		font-size: 0.9rem;
	}

	.cost-label {
		color: #718096;
	}

	.cost-amount {
		color: #2d3748;
		font-weight: 500;
	}

	/* Additional Tests */
	.additional-tests {
		display: grid;
		grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
		gap: 1rem;
		margin: 1.5rem 0;
	}

	.test-item {
		display: flex;
		flex-direction: column;
		padding: 1rem;
		background: #f8fafc;
		border-radius: 8px;
		border-left: 3px solid #667eea;
	}

	.test-item strong {
		color: #2d3748;
		margin-bottom: 0.25rem;
	}

	.test-item span {
		color: #718096;
		font-size: 0.9rem;
	}

	/* Treatment Cards */
	.treatment-cards {
		display: grid;
		grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
		gap: 1.5rem;
		margin: 1.5rem 0;
	}

	.treatment-card {
		background: white;
		border-radius: 12px;
		overflow: hidden;
		box-shadow: 0 2px 8px rgba(0,0,0,0.08);
		border: 1px solid #e2e8f0;
	}

	.treatment-header {
		display: flex;
		justify-content: space-between;
		align-items: center;
		padding: 1rem 1.25rem;
		color: white;
	}

	.treatment-header.aps {
		background: linear-gradient(135deg, #fc8181 0%, #f56565 100%);
	}

	.treatment-header.uterine {
		background: linear-gradient(135deg, #f687b3 0%, #ed64a6 100%);
	}

	.treatment-header.genetic {
		background: linear-gradient(135deg, #b794f4 0%, #9f7aea 100%);
	}

	.treatment-header.thyroid {
		background: linear-gradient(135deg, #f6ad55 0%, #ed8936 100%);
	}

	.treatment-header h4 {
		margin: 0;
		font-size: 1.1rem;
	}

	.success-badge {
		background: rgba(255,255,255,0.2);
		padding: 0.25rem 0.75rem;
		border-radius: 20px;
		font-size: 0.8rem;
	}

	.treatment-body {
		padding: 1.25rem;
	}

	.treatment-body ul {
		margin: 0.5rem 0;
		padding-left: 1.25rem;
	}

	.contrast-note {
		color: #718096;
		font-size: 0.9rem;
		font-style: italic;
	}

	.treatment-cost {
		margin-top: 1rem;
		padding-top: 0.75rem;
		border-top: 1px solid #e2e8f0;
		color: #667eea;
		font-weight: 600;
	}

	/* Empiric Grid */
	.empiric-grid {
		display: grid;
		grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
		gap: 1.5rem;
		margin: 1.5rem 0;
	}

	.empiric-card {
		background: white;
		border-radius: 12px;
		padding: 1.5rem;
		box-shadow: 0 2px 8px rgba(0,0,0,0.08);
		border: 1px solid #e2e8f0;
	}

	.empiric-card h4 {
		margin: 0 0 0.75rem;
		color: #2d3748;
	}

	.evidence-note {
		background: #f0fff4;
		padding: 0.75rem;
		border-radius: 6px;
		margin-top: 1rem;
		font-size: 0.9rem;
		color: #276749;
	}

	.empiric-cost {
		margin-top: 1rem;
		color: #667eea;
		font-weight: 600;
	}

	/* Options Grid */
	.options-grid {
		display: grid;
		grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
		gap: 1.5rem;
		margin: 1.5rem 0;
	}

	.option-card {
		background: white;
		border-radius: 12px;
		padding: 1.5rem;
		box-shadow: 0 2px 8px rgba(0,0,0,0.08);
		border: 1px solid #e2e8f0;
	}

	.option-card h3 {
		margin: 0 0 1rem;
		font-size: 1.25rem;
	}

	.option-card ul {
		margin: 0.5rem 0 1rem;
		padding-left: 1.25rem;
	}

	.option-link {
		color: #667eea;
		font-weight: 500;
		text-decoration: none;
	}

	.option-link:hover {
		text-decoration: underline;
	}

	/* Support Options */
	.support-options {
		display: grid;
		grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
		gap: 1.5rem;
		margin: 1.5rem 0;
	}

	.support-item {
		display: flex;
		gap: 1rem;
		align-items: flex-start;
		padding: 1.25rem;
		background: #f8fafc;
		border-radius: 8px;
	}

	.support-icon {
		font-size: 1.5rem;
		flex-shrink: 0;
	}

	.support-item strong {
		display: block;
		color: #2d3748;
		margin-bottom: 0.25rem;
	}

	.support-item p {
		margin: 0;
		color: #718096;
		font-size: 0.95rem;
	}

	/* Questions List */
	.questions-list {
		display: flex;
		flex-direction: column;
		gap: 0.75rem;
		margin: 1.5rem 0;
	}

	.question-item {
		display: flex;
		align-items: center;
		gap: 1rem;
		padding: 1rem;
		background: white;
		border-radius: 8px;
		box-shadow: 0 1px 3px rgba(0,0,0,0.1);
	}

	.question-number {
		width: 28px;
		height: 28px;
		background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
		color: white;
		border-radius: 50%;
		display: flex;
		align-items: center;
		justify-content: center;
		font-weight: 600;
		font-size: 0.9rem;
		flex-shrink: 0;
	}

	/* Navigation Footer */
	.nav-footer {
		display: flex;
		justify-content: space-between;
		margin-top: 3rem;
		padding-top: 2rem;
		border-top: 2px solid #e2e8f0;
		gap: 1rem;
	}

	.nav-prev, .nav-next {
		display: flex;
		flex-direction: column;
		padding: 1rem 1.5rem;
		background: white;
		border-radius: 8px;
		text-decoration: none;
		border: 1px solid #e2e8f0;
		transition: all 0.2s;
	}

	.nav-prev:hover, .nav-next:hover {
		border-color: #667eea;
		box-shadow: 0 2px 8px rgba(102, 126, 234, 0.15);
	}

	.nav-next {
		text-align: right;
	}

	.nav-direction {
		font-size: 0.85rem;
		color: #718096;
	}

	.nav-title {
		color: #667eea;
		font-weight: 600;
	}

	@media (max-width: 768px) {
		.hero-mini h1 {
			font-size: 2rem;
		}

		.stats-grid-3 {
			grid-template-columns: 1fr;
		}

		.progress-content {
			flex-direction: column;
			gap: 0.25rem;
		}

		.nav-footer {
			flex-direction: column;
		}

		.nav-next {
			text-align: left;
		}
	}
</style>
